We expect to receive solutions on transportable and compact pharma / biopharma production systems for point-of-use production of 1-1,000 doses on demand.
Same quality and acceptable cost compared to current pharma manufacturing. Integrated bioproduction system. Raw materials, culture media, chemicals business enabling the integrated API or biologics synthesis (new quality grade, new packaging, new distribution model). Cell-free or engineered, dried stored, cells or bacteria (tunable to select which drug has to be produced from a set of choices). Integrated product attributes and biomonitoring tools (on-line bioburden, sterility testing release).
Globally acting multinational organization with two digits billion sales, a substantial investment in R&D, and a strong commitment to both its customers and its shareholders. Major research and production sites across Europe, in the US and the Asian-Pacific area.
Details of the Technology Call
On demand single dose production systems do not exist as a commercial product. How can micro reactor and continuous flow technology be applied to oral solid drugs (API) and biologics. Pharmacy on-demand (single or weekly doses) motivated by a need in hard-to-access, battlefield, disaster areas or in hospitals (personalized medicines) or even long-term move to personal homes?
Possible solution areas
Previously attempted solutions (discarded)